First results of the interim analysis of the randomized controlled SVASONA trial for idiopathic normal pressure hydrocephalus (ISRCTN51046698)

Ullrich Meier, Johannes Lemcke, Cornelia Müller, Michael Fritsch, Michael Kiefer, Regina Eymann, Uwe Kehler, Niels Langer, Veit Rohde, Hans-Christoph Ludwig, Friedrich Weber, Veceslav Remenez, Martin Schuhmann & Dirk Stengel
Objective: The idiopathic normal-pressure hydrocephalus (iNPH) is a neurodegenerative disease which may be responsible for up to 6% of all dementia cases. The surgical implantation of a ventriculoperitoneal shunt represents the current standard of care. The results of the prospective Dutch iNPH[for full text, please go to the a.m. URL]